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The housekeeping enzyme xanthine oxidoreductase 
(XOR) has been studied intensively over the past 100 
years, yet the complexity of its in vivo function is still 
poorly understood. A large body of literature focuses on 
the different catalytic forms of XOR and their import­
ance in the synthesis of reactive oxygen and reactive 
nitrogen species, which are involved in many disease 
processes. More recently, various protective physiologi­
cal roles of XOR have been recognized. We summarize 
for the first time that XOR is a component of the innate 
immune system. Because XOR is involved in multiple 
features of innate immunity we suggest that it is central 
to the evolution and function of this ancient defense 
system. We present evidence suggesting that XOR is a 
direct downstream target of the evolutionarily con­
served Toll-like receptor-NF-KB pathway and discuss 
that numerous forms of post-translational modification 
of XOR could provide intrinsic molecular switches that 
make XOR an ideal component of various fast innate 
immune responses.
Xanthine oxidoreductase (XOR) is best known as an 
evolutionarily conserved housekeeping enzyme with a 
principal role in purine catabolism [1,2]. Humans with 
mutations in XOR suffer from xanthinuria, an autosomal- 
recessive disorder resulting in kidney stone formation and 
urinary tract disorders [3]. By generating mice with a 
targeted disruption of XOR, we discovered the additional 
role of XOR as an essential protein for milk fat droplet 
secretion from the lactating mammary gland [4]. This 
surprising function prompted us to review the complex 
role of XOR in mammals and throughout the animal 
kingdom. There is increasing evidence that XOR has 
additional physiological functions associated with its 
synthesis of reactive oxygen species (ROS) and reactive 
nitrogen species (RNS), which have important roles in 
inflammation and host defense [5,6]. Here, we propose for 
the first time that XOR is an evolutionarily conserved 
component of the innate immune system.
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XOR performs various cellular protective functions 
central to the innate immune system
In purine catabolism, XOR catalyzes the oxidative 
hydroxylation of hypoxanthine to xanthine and sub­
sequently of xanthine to uric acid [1,2]. This, and 
presumably other, metabolic reactions of XOR have a 
far-reaching impact on cellular homeostasis, cellular 
protection from toxic compounds and also systemic 
protection, known as innate immunity Uric acid and its 
oxidation product allantoin act as potent antioxidants and 
free radical scavengers, necessary to protect a cell from 
oxidative damage caused by numerous naturally occurring 
ROS and RNS [7-9]. XOR has, therefore, important 
functions as a cellular defense enzyme against oxidative 
stress. Interestingly, XOR itself contributes to the syn­
thesis of numerous ROS and RNS [1,2,5,6]. XOR exists in 
two forms, as xanthine dehydrogenase (XD; EC 1.1.1.204), 
which is the primary gene product of XOR, and as xanthine 
oxidase (XO; EC 1.1.3.22), which is formed through post- 
translational modifications of XD. XD favors the cofactor 
NADT as its primary electron acceptor, yetXO is unable to 
bind NAD+ and uses 02 as its electron acceptor. With both 
forms, but particularly with the XO form, numerous ROS 
and RNS are synthesized [1,2,5,6]. Consequently, the 
synthesis of both an antioxidant (uric acid) and numerous 
free radicals (ROS and RNS) makes XOR an important 
protective regulator of the cellular redox potential [10]. 
Moreover, XOR is also a potent detoxification enzyme, 
probably owing to its multifunctional enzymatic activities 
[11]. This detoxification function is not restricted to XOR 
but is rather generally found in the molybdopterin family 
of enzymes, including aldehyde oxidase (AO) [11]. In this 
context, AO is of particular interest because its amino acid 
identity and its intron-exon structure is similar to XOR, 
suggesting that both enzymes evolved through gene 
duplications [12]. Not surprisingly, XOR and AO have a 
large number of common substrates and similar 
expression patterns [12].
The innate immune system is an evolutionarily 
conserved, rapid, non-specific first-line defense mechan­
ism that incorporates elements of cellular differentiation 
and protection against oxidative stress [13]. Innate 
immunity is composed of: (i) surface epithelia that provide 
local physical and molecular barriers, (ii) inflammatory
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reactions and the activation of conserved cell-signaling 
pathways, (iii) numerous systemic protective molecules 
and (iv) various phagocytotic cells. All of these components 
work together to resist and prevent the action of toxic 
molecules and the rapid spread of potentially fatal 
pathogens. The protective functions of XOR in innate 
immunity are, as at the cellular level, linked to its 
detoxification reactions, its synthesis of uric acid and, 
particularly, its synthesis of numerous ROS and RNS.
Uric acid not only acts as a cellular but also as a 
systemic antioxidant. and free radical scavenger, besides 
being an anti-inflammatory effector with numerous 
protective roles in the body [14-16]. ROS and RNS 
perform, at low levels, numerous cellular and physiological 
functions as second messengers but, at high levels, can act 
as microbicidals [17-19] (Fig. 1). XOR generates the ROS 
superoxide anions (O2), hydroxyl radicals (OH') and 
hydrogen peroxide (H2O2) [20]. Those ROS can generate 
an entire cascade of microbicidal reactions and products by 
participating in the synthesis of additional antimicrobial 
and cytotoxic molecules, thereby broadening their range of 
action [21]. RNS derive from the free radical nitric oxide 
(NO), a product of NO synthase as well as XOR [22], NO 
itself is antimicrobial and cytotoxic, and it is further 
involved in the generation of an array of reactive molecules 
and even more potent antimicrobial substances, which 
makes NO a defensive molecule against various patho­
gens, tumor cells and alloantigens [23,24]. XO has also 
been implicated in protective antiviral responses by 
catalyzing the conversion of retinaldehyde to retinoic 
acid. Derivatives of retinoic acid can inhibit viral replica­
tion, thus potentially preventing the spread of viral 
diseases [25]. As we summarize here, XOR and its products 
are directly and/or indirectly involved in multiple features 
of innate immunity in mammals and, furthermore,
have a conserved defense function throughout the animal 
kingdom.
XOR is expressed and secreted by numerous surface 
epithelia
Because most pathogens enter the body through surface 
membranes, epithelial tissues are an important com­
ponent of the non-specific immune system. Surface 
epithelia have evolved many defense mechanisms, 
among which are the expression and secretion of numer­
ous molecules. These molecules perform broad-spectrum 
antimicrobial functions by neutralizing and inactivating 
pathogens and/or by generating transient microbicidal 
and cytotoxic substances, such as ROS and RNS. As a 
housekeeping enzyme, XOR is presumably expressed in all 
cells, yet, high levels of constitutively expressed XOR, as 
well as AO, are found in many mammalian epithelial and 
capillary endothelial tissues of various organs [26-29]. 
The intensity of XOR activity appears to be organ- 
dependent. [28,29]. Numerous pathogens, cytokines, as 
well as many forms of tissue damage, can rapidly induce 
additional expression and translation of XOR [5]. 
Although XD is the predominant XOR form found in 
normal cells and tissues, XO appears to have an important 
role in cell and tissue injuries [5,6]. Various forms of 
stimuli induce the conversion of the XD to the XO form, 
presumably resulting in intensive synthesis of ROS and 
RNS [5,6],
XOR and uric acid are also secreted on the surface of 
(mucosal) epithelial tissues, thereby expanding their 
protective function extracellularly. Uric acid is found in 
nasal fluid, saliva and many other body fluids [14,30,31]. 
Uric acid is also released from the heart and the 
microvascular endothelium was identified as its site of 
formation [32]. XOR itself is constitutively released by
Xanthine dehydrogenase (XD): (predominant in normal tissue)
Xanthine + NAD+ + H2O -— ► Uric acid + NADH
Antioxidant
XD -  XO conversion
Xanthine oxidase (XO): (predominant in injury and disease)
Substrate + O2 + H2O ----- ► Product + O2-  and other ROS, RN
V. J
Y
ROS and RNS act at low level as important
second messengers and at high level as
microbicidals that further participate in the
synthesis of additional antimicrobial and
cytotoxic molecules.
TRENDSin Immunology
Fig, 1. XOR is a housekeeping enzyme with a role in purine catabolism, detoxification and the regulation of the cellular redox potential. XOR exists in two enzymatic forms, 
as a XD and as an XO. XD is the form that predominates in purine catabolism resulting in the synthesis of the antioxidant uric acid. The XO form is associated with the syn­
thesis of large amount of ROS and RNS, which at low levels are important second messengers but at high levels have microbicidal action. The ability of XOR to rapidly con­
vert from XD to XO under various forms of tissue injury and damage makes XOR an ideal component for a fast innate immune response. Abbreviations: NAD, nicotinamide 
adenine dinucleotide; ROS, reactive oxygen species; RNS reactive nitrogen species; XD,xanthine dehydrogenase; XO,xanthine oxidase; XOR,xanthine oxidoreductase.
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pulmonary microvascular endothelial cells and found on 
the outside surface of endothelial plasma membranes of 
various organs [33-35]. More importantly, XOR is 
secreted by the lactating mammary gland and the small 
intestine for an antimicrobial purpose [19,36,37]. 
Although the mammary gland and milk provide immuno­
logical protection for the offspring, the intestine needs an 
intensive immune defense owing to its expansive 
epithelial surface, its multitude of villi and narrow 
invaginations, its exposure to dietary antigens and its 
proximity to the colon. XOR activity was detected in 
enterocytes and in the mucous of duodenum [38]. 
Within the small intestine, XOR was detected in 
Paneth cells, which are specialized epithelial cells 
that secrete various antimicrobial molecules in respon- 
sonse to bacterial and other stimuli [39].
XOR is a mediator of infection and inflammation and 
interacts with NF-kB and activator protein-1 (AP-1)
Inflammatory reactions are an important part of innate 
immunity, comprising a sequence of events induced by 
various forms of tissue damage and infection. The 
inflammatory reaction results in the expression of various 
cytokines and XOR is stimulated by interferon-7 (IFN-'y), 
IFN-a, tumor necrosis factor-a (TNF-a), interleukin-1 
(IL-1) and IL-3; some of these factors also initiate the 
conversion from the XD to the XO form [5,6]. Endothelial 
XOR was suggested to trigger a microvascular inflamma­
tory response, leading to recruitment and activation of 
circulating neutrophils and trapping of circulating patho­
gens [6]. The recruitment of neutrophils and the activation 
of macrophages are induced by ROS that upregulate cell 
adhesion molecules [40,41]. ROS from XOR and NADPH 
oxidase mediate the expression of endothelial-cell surface 
P-selectin, one of the first cell-surface molecules to be 
expressed on the endothelial cell in response to inflam­
mation [42].
Throughout evolution, pathogen-induced stimulation of 
the innate immune system relies on numerous conserved 
Toll-like receptors (TLRs), which initiate intracellular 
signaling cascades that subsequently activate the tran­
scription factors NF-kB and AP-1 [43,44]. NF-kB controls a 
wide variety of immune-inducible antimicrobial mol­
ecules, including ROS and RNS, as well as cytokines and 
co-stimulatory molecules [45]. Binding sites for NF-kB and 
AP-1, as well as for response elements for cytokines, have 
been identified in the 5' UTR (untranslated region) of the 
human XOR gene and both NF-kB and XOR are 
stimulated by bacterial lipopolysaccharids (LPS) in vivo 
[28,46,47]. This suggests that XOR is a downstream target 
of the TLR-NF-kB pathway and is directly activated by 
NF-kB and AP-1. Yet, both transcription factors are also 
stimulated by the redox potential of the cell and XOR 
might, therefore, also regulate the expression of NF-kB 
and AP-1 [48,49]. The application of an inhibitor for XOR 
leads to a dose-dependent inhibiton of NF-kB during 
hepatic ischemia-reperfusion, and AP-1 is downregulated 
following the synthesis of NO [50,51]. Consequently, we 
suggest intensive cross talk between XOR, the TLR-NF- 
kB pathway and the transcription factors NF-kB and AP-1.
XOR participates in systemic protection and 
detoxification
XOR activity and uric acid are generally found in the blood 
plasma of many mammalian species and levels are 
particularly high during numerous disease states [5]. 
XOR might participate in the systemic antimicrobial 
response of the innate immune system by providing an 
oxidative defense mechanism in the blood. XOR is reported 
to have a defense role in meningitis, malaria and in 
trypanosomiasis [15,52,53]. Serum XOR is predominantly 
in the XO form, as a result of serum proteases [54]. XOR 
and the synthesis of ROS have also been implicated in the 
activation of the complement system, an important feature 
of the systemic innate immune system [55,56].
XOR is highly expressed in the liver for purine 
catabolism and nitrogen elimination as well as for 
systemic detoxification. XOR and AO are both important 
for the biotransformation of numerous toxic compounds 
[11]. Yet, the liver is also an organ for systemic bacterial 
scavenging, inactivation of bacterial products and inflam­
matory mediator clearance and production [57]. Liver 
Kupffer cells are a major source of ROS and proinflamma- 
tory cytokines that are produced in response to LPS, 
making the liver a key organ for the killing of circulating 
microorganisms [58]. ROS generated by both XOR and 
NADPH oxidase-dependent pathways are important for 
the systemic killing of Candida parapsilosis by Kupffer 
cells and the inhibition of XO activity leads to significant 
reduction of hepatic killing of various bacterial strains 
[59-62]. Furthermore, the liver produces various anti­
microbial serum proteins that are released in response to 
infection or inflammation and generally are known as the 
acute phase proteins. The way cytokines stimulate XOR 
activity is similar to an acute phase response, and XOR 
might also be considered to participate in this feature of 
innate immunity [5,53]. Several other tissues and organs 
upregulate XOR in response to systemic infections, 
including the spleen, which is the major organ for 
pathogenic scavenging [28,63].
XOR has an important role in phagocytotic killing
Innate and adaptive immunity rely on the activity of 
phagocytotic cells that release numerous molecules, 
including ROS, for the intracellular destruction of phago- 
cytosed microorganisms and for extracellular toxic effects 
on pathogens and tumor cells. Several enzymes are 
responsible for the synthesis of ROS in phagocytes and 
experiments suggest that XOR also participates in the 
innate immune response of phagocytotic cells [18,21]. 
Animals infected with Staphylococcus aureus, Salmonella 
typhimurium, Plasmodium berghei, Schistosoma man- 
soni, Listeria, various viruses and Ehrlich hyperdiploid 
carcinoma cells, all show a marked increase in XO activity 
in phagocytotic cells. Most of the XOR activity found in 
these infected animals is in the XO form. The adminis­
tration of XOR inhibitors to infected animals leads to a 
decrease in the bactericidal activity of phagocytes and a 
linear dose-increase in mortality. Administration of 
purified XO or xanthine, a XOR substrate, to infected 
animals, results in significant protection against bacterial 
infections [61,64,65]. Furthermore, XOR contributes to
http://trei mm, trends, com
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host defense against Burkholderia cepacia and phagocytic 
destruction of Candida parapsilosis by murine peritoneal 
macrophages [66,67].
XOR participates in the innate immune system 
throughout the animal kingdom
XOR has general cellular protective functions, presumably 
present in all eukaryotic and most prokaryotic cells. Yet, 
there is evidence that its role in systemic protection and 
innate immunity is also conserved. Because innate 
immunity is evolutionarily ancient and preceded adaptive 
immunity [68], the protective role of XOR in the innate 
immune system of lower organisms might be particularly 
crucial for their defense and survival. Invertebrates 
possess an efficient innate immune system composed of 
cellular and humoral elements. The humoral defense 
includes antimicrobial peptides, the cascades that regulate 
coagulation and melanization of hemolymph, and the 
production of ROS and RNS [69]. The involvement of 
cytotoxic ROS and RNS in innate immunity has been 
studied intensively in Drosophila and other insects, as 
well as in bivalve mollusks [21,24,70,71]. Uric acid is 
known to occur in large amounts in Drosophila and a 
decline of this antioxidant with age could be associated 
with the loss of antioxidant potential in aging [72]. The 
melanization reaction is performed by many arthropods as 
part of the innate immune system and triggered by injury 
and recognition of microbial eell-wall composition. Mela­
nization leads to the synthesis and deposition of melanin in 
wounded areas, resulting in wound healing, synthesis of 
toxic products (including ROS and RNS), sequestration, 
encapsulation and killing of invading microorganisms 
[73,74]. XOR and ROS have been implicated in the 
synthesis of melanin and it has been postulated that 
the melanization of skin and other tissues is also an 
important component of the innate immune system of 
vertebrates [75].
In mammals, XOR, as well as AO, is involved in 
numerous hepatic and epithelial detoxification reactions. 
In insects, insecticide resistance and insecticide detoxifi­
cation are important host defense mechanisms, resulting 
in the upregulation of various metabolic enzymes. These 
enzymes are also involved in anabolism and catabolism of 
a multitude of endogenous compounds and the protection 
against oxidative stress [76]. AO is coamplified with the 
Culex mosquito insecticide resistance-associated esterases 
and its 5; flanking region contains binding sites, known 
from other insecticide resistance genes [12,77]. As men­
tioned, the TLR—NF-xB-signaling cascade has a central 
role in innate immunity throughout the animal kingdom 
and crosstalk between XOR, ROS and NF-kB has been 
outlined.
The complex and versatile role of XOR, particularly in 
the mammalian innate immune system, could be linked to 
the unique rapid post-translational conversion from the 
XD to the XO form. Only mammalian XOR, but not XOR 
from chicken and Drosophila, can be converted from the 
XD to the XO form experimentally. XD is reversibly 
converted to XO by thiol oxidation or irreversibly by 
limited proteolysis [2,78]. The mechanism for this conver­
sion might have evolved very recently. Phylogenetic
analysis of the presence of various oxidases demonstrate 
that although the XD form of XOR is present throughout 
all vertebrates except reptiles, the XO form is only found in 
mammals. XOR in its XD form is abundant in insects, 
although crustacea and gastropoda seem to have much 
higher levels of AO than XOR. Neither XOR nor AO 
activity was detectable in Porifera, Coelenterata, Platy- 
helminthes, Nemathelminthes and Nemertea [79]. This 
suggests that the systemic protective role of XOR, and 
probably also of AO, is found predominantly in higher 
invertebrates and presumably, throughout all vertebrates, 
with a particular complex function in mammals. The 
possibility to rapidly, reversibly convert XOR from the XD 
to the XO form, might provide mammals with a powerful 
intrinsic switch, ideally suited as a component for a rapid, 
transient, innate immune response, independent of 
immunological memory. In general, most effector 
molecules of innate immunity need a fast conversion 
from a pre-existing, inactive to an active form, which is 
usually achieved by proteolytic processing of a pre­
cursor molecule [80]. Yet, other forms of post-transla­
tional activation of XOR could be of similar importance 
and the strong emphasis of the literature on the XD to 
XO conversion has been questioned [5,6]. XOR also 
exists in enzymatic inactive demolybdo and desulfo 
forms [5]. Experiments show that a desulpho-sulpho 
conversion of XOR is associated with an increase in 
XOR activity [5]. Moreover, activation of XOR by 
phosphorylation has been suggested [81]. It is possible 
that various forms of post-translational activation of 
XOR might act as switches for the complex role of XOR 
in numerous fast innate immune responses.
Conclusions
The ability of the multifunctional enzyme XOR to perform 
general detoxification reactions and additionally, to 
synthesize large amounts of the antioxidant uric acid, as 
well as ROS and RNS, makes it a versatile intra- and 
extra-cellular protective housekeeping enzyme and an 
important component of the innate immune system. XOR 
is involved in numerous features of mammalian innate 
immunity but, furthermore, its protective role appears to 
be evolutionarily conserved and downstream of the TLR— 
NF-kB pathway. Because numerous features of the innate 
immune system include oxidative defense and XOR and 
elements of cellular oxidative protection predated the 
existence of the innate immune system, we suggest that 
XOR is a central molecule in the evolution and function of 
this ancient defense system (Fig. 2). Because the innate 
immune response generates many signals that eo-stimu- 
late the adaptive immune system, it is possible that XOR 
also has a role in the crosstalk between innate and 
adaptive immunity.
As mentioned, we recently discovered that XOR also has 
an essential role in milk fat droplet secretion from the 
lactating mammary gland. How XOR and the innate 
immune system contributed to the evolution of the 
mammary gland, milk and the entire class mammalia, 
will be discussed in another communication (C. Vorbach 
and M. Capecchi, unpublished).
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Fig, 2. XOR is an evolutionarily conserved housekeeping enzyme, important for purine catabolism, detoxification and the regulation of the cellular redox potential. Interest­
ingly, the same protective functions are involved in multiple features of the innate immune system, suggesting that XOR is a central molecule in the evolution and function 
of this ancient defense system. Because innate immune responses generate many signals that eo-stimulate the adaptive immune system it is possible that XOR also has a 
role in the crosstalk between innate and adaptive immunity. Abbreviations: AP-1, activator protein-1, XOR, xanthine oxidoreductase.
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